Provided by Tiger Fintech (Singapore) Pte. Ltd.

SAB Biotherapeutics, Inc.

2.30
+0.02000.88%
Pre-market: 2.300.00000.00%06:04 EDT
Volume:118.76K
Turnover:273.81K
Market Cap:21.37M
PE:-0.62
High:2.39
Open:2.26
Low:2.22
Close:2.28
Loading ...
Nov 02, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Nov 01, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Nov 01, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Oct 28, 2021

Major Issues Report

8-K - Current report
Oct 22, 2021

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Oct 21, 2021

Major Issues Report

8-K - Current report
Oct 19, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 13, 2021

Major Issues Report

8-K - Current report
Oct 13, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Oct 12, 2021

Major Issues Report

8-K - Current report
Oct 12, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Oct 07, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Oct 04, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 28, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 27, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 22, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 08, 2021

Correspondence

CORRESP [Cover] - Correspondence